Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Oncolytic zika virus therapy leverages CCR2+ monocytes to boost anti-glioblastoma T cell responses.
Journal: Neuro-oncology
Published: April 28, 2025
Oligoadenylate synthetase 1 displays dual antiviral mechanisms in driving translational shutdown and protecting interferon production.
Journal: Immunity
Published: June 15, 2023
Zika virus oncolytic activity requires CD8+ T cells and is boosted by immune checkpoint blockade.
Journal: JCI insight
Published: September 23, 2020
Publisher Correction: SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function.
Journal: Nature immunology
Published: September 04, 2020
SARS-CoV-2 infection in the lungs of human ACE2 transgenic mice causes severe inflammation, immune cell infiltration, and compromised respiratory function.
Journal: bioRxiv : the preprint server for biology
Published: July 18, 2020
Implementing an Evidence-Based, Asthma Decision Support Tool for Children Younger Than 5 Years Old.
Journal: Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners
Published: June 15, 2018
Irg1 expression in myeloid cells prevents immunopathology during M. tuberculosis infection.
Journal: The Journal of experimental medicine
Published: January 19, 2018
Mxra8 is a receptor for multiple arthritogenic alphaviruses.
Journal: Nature
Published: December 08, 2017
Interferon Regulatory Factor 1 Protects against Chikungunya Virus-Induced Immunopathology by Restricting Infection in Muscle Cells.
Journal: Journal of virology
Published: August 18, 2017
Type I Interferon response in olfactory bulb, the site of tick-borne flavivirus accumulation, is primarily regulated by IPS-1.
Journal: Journal of neuroinflammation
Published: October 28, 2015
Last Updated: 09/26/2026